Current Trends in Colorectal Cancer Screening
- 12 Downloads
Purpose of Review
The following review is to assess the current methods, both non-invasive and invasive, in colorectal cancer screening and discuss novel screening techniques.
Colorectal cancer continues to affect millions of people across the world. Through increased and widespread adoption of various screening methods, the rates of colon cancer-related deaths are decreasing. However, this decline has not been observed worldwide, possibly due to the lack of widespread screening adoption. Although there are many methods for screening colorectal cancer, colonoscopy remains the gold standard, due to high sensitivity and specificity as well as the ability to immediately sample or remove concerning tissue. Blood-based molecular testing is the most recent advancement in colorectal cancer screening; however, it has a significantly lower sensitivity and specificity when compared to other methods. However, with continued investigation, blood-based molecular testing may change how we screen for colorectal cancer in the near future.
Several options for colorectal cancer screening exist today. Colorectal cancer screening methods and techniques have improved over the last several decades. These improvements have helped to decrease the rates of colorectal cancer-related deaths, most notably in the USA. Various organizations have provided a list of recommendations and suggested screening agendas, which will be reviewed in this discussion.
KeywordsColorectal cancer Screening Colonoscopy Sigmoidoscopy FIT FOBT Colonography Stool DNA
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 5.Simkin J, et al. Differences in colorectal cancer screening rates across income strata by levels of urbanization: results from the Canadian Community Health Survey (2013/2014): Can J Public Health; 2018;110(1):62–71.Google Scholar
- 8.Colorectal Cancer Facts & Figures 2017-2019., A.C. Society, Editor. 2017; Atlanta.Google Scholar
- 9.Gupta S, et al. Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial. JAMA Intern Med. 2013;173(18):1725–32.Google Scholar
- 21.CY 2018 Medicare Fee Schedule Changes (National Estimates), C.f.M.a.M. Services, Editor. 2018.Google Scholar
- 34.• Prince M, et al. Multitarget stool DNA tests increases colorectal cancer screening among previously noncompliant Medicare patients. World J Gastroenterol. 2017;23(3):464–71 An important cross-sectional study with real-world applications demonstrating how a multitarget stool DNA test can significantly improve colorectal cancer screening. Google Scholar
- 37.Kim YC, et al. The usefulness of a novel screening kit for colorectal cancer using the immunochromatographic fecal tumor M2 pyruvate kinase test. Gut Liver. 2015;9(5):641–8.Google Scholar
- 50.Chen CH, Yan SL, Yang TH, Chen SF, Yeh YH, Ou JJ, et al. The relationship between the methylated septin-9 DNA blood test and stool occult blood test for diagnosing colorectal cancer in Taiwanese people. J Clin Lab Anal. 2017;31(1). https://doi.org/10.1002/jcla.22013
- 53.Marshall KW, et al. A blood-based biomarker panel for stratifying current risk for colorectal cancer. Int J Cancer. 2010;126(5):1177–86.Google Scholar
- 54.• Bray C, et al. Colorectal cancer screening. WMJ. 2017;116(1):27–33 The development of a risk-stratification tool using molecular testing with exciting implications for streamlined colorectal cancer screening. Google Scholar
- 57.Yiu AJ, Yiu CY. Biomarkers in colorectal cancer. Anticancer Res. 2016;36(3):1093–102.Google Scholar
- 60.Chen H, et al. Prospective evaluation of 64 serum autoantibodies as biomarkers for early detection of colorectal cancer in a true screening setting. Oncotarget. 2016;7(13):16420–32.Google Scholar
- 64.•• Check-CapAbbounces FDA Conditional Approval of IDE to Initiate U.S. Pilot Study of C-Scan. 2018 1/4/2019]; Available from: http://ir.check-cap.com/2018-12-13-Check-Cap-Announces-FDA-Conditional-Approval-of-IDE-to-Initiate-U-S-Pilot-Study-of-C-Scan-R Exciting news announcing the initiation of a pilot study regarding preparation-free capsule-based colorectal cancer screening.
- 65.Outsense Toilet IOT Sensor. 1/4/2019]; Available from: https://outsense.co.il/.
- 67.•• Urban G, et al. Deep learning localizes and identifies polyps in real time with 96% accuracy in screening colonoscopy. Gastroenterology. 2018;155(4):1069–78 e8 Important machine-learning algorithms to improve polyp detection during colonoscopy, making invasive testing more effective. Google Scholar